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ABSTRACT Calmodulin (CaM) mediates Ca-dependent regulation of numerous pathways in the heart, including CaM-
dependent kinase (CaMKII) and calcineurin (CaN), yet the local Ca21 signals responsible for their selective activation are unclear.
To assess when and where CaM, CaMKII, and CaN may be activated in the cardiac myocyte, we integrated new mechanistic
computational models of CaM, CaMKII, and CaN with the Shannon-Bers model of excitation-contraction coupling in the rabbit
ventricular myocyte. These models are validated with independent in vitro data. In the intact myocyte, model simulations predict
that CaM is highly activated in the dyadic cleft during each beat, but not appreciably in the cytosol. CaMKII-dC was almost
insensitive to cytosolicCadue to relatively lowCaMafﬁnity. Dyadic cleft CaMKII exhibits dynamic frequency-dependent responses
to Ca, yet autophosphorylates only when local phosphatases are suppressed. In contrast, dyadic cleft CaN in beating myocytes is
predicted to beconstitutively active,whereas theextremely highafﬁnity ofCaN forCaMallowsgradual integration of small cytosolic
CaM signals. Reversing CaMafﬁnities for CaMKII andCaN also reverses their characteristic local responses. Deactivation of both
CaMKII and CaN seems dominated by Ca dissociation from the complex (versus Ca-CaM dissociation from the target). In
summary, the different afﬁnities of CaM for CaMKII and CaN determine their sensitivity to local Ca signals in cardiac myocytes.
INTRODUCTION
Calcium is a highly versatile second messenger in the heart,
playing a central role in the regulation of both excitation-con-
traction (EC) coupling and excitation-transcription coupling.
However, how these short- and long-term Ca-dependent
functions are selectively regulated is an important and un-
answered question in cardiac biology (1,2). Many of the Ca-
dependent pathways are channeled through the same Ca sensor,
calmodulin (CaM) (3), so it is unclear how these pathways can
selectively respond to external stimuli in a context-dependent
manner.
Ca signaling is increasingly recognized tobecompartmented
(4), and local control of Ca signaling pathways could provide a
mechanism for context-dependent signaling. Furthermore, Ca-
CaM-dependent signaling proteins exhibit a large range of af-
ﬁnities that may affect how they respond to local Ca signals.
Calcineurin (CaN), a protein phosphatase thought to play a
major role in cardiac hypertrophy, binds Ca4CaM at a ‘‘high’’
afﬁnity: Kd; 28 pM (5). In contrast, CaM-dependent protein
kinase II (CaMKII), which regulates apoptosis, transcription,
and excitation-contraction coupling, binds Ca4CaM at a lower
afﬁnity:Kd; 33.5 nM for the cardiac (d) isoform (6). Here, we
integrate an experimentally validated computational model of
cardiac myocyte excitation-contraction coupling (7,8) with
new reactionmodels derived from the biochemical literature to
determine when and where CaM, CaN, and CaMKII are acti-
vated by local Ca signals (seeFig. 1A). Thismechanisticmodel
predicts that CaMKII is responsive only when targeted to Ca
release sites such as the dyadic cleft, CaN is only responsive to
gradual changes in the lower-amplitude cytosolic Ca signals,
and these diverging responses can be quantitatively explained
by their different afﬁnities for CaM. These results support the
idea that diverse CaMbinding afﬁnitiesmay facilitate selective
regulation ofCa-dependent pathways byﬁne-tuning sensitivity
to particular local Ca signals.
METHODS
Equations and parameters, with references for all newmodel components, are
detailed in the Appendix, but their motivation is provided here. An overall
model schematic is shown in Fig. 1 A, with detailed diagrams of the reactions
for individual modules in Fig. 1, B–D. Model parameters were obtained from
the biochemistry literature (see Tables 1–3) and predictions were validated
with experimental data from the literature, as shown in Figs. 2 and 3. Several
parameters were derived from the principle of detailed balance. Detailed
balance (microscopic reversibility) requires that at chemical equilibrium, the
chemical-potential difference of all reactions is zero, which constrains the
product of equilibrium constants in a reaction loop to equal 1 (9). All simu-
lationswere performed inMATLAB(TheMathWorks,Natick,MA)using the
stiff ode15s solver, and code is freely available on request.
Calmodulin (CaM) module
Calmodulin binds four Ca ions: two to the carboxyl or C-terminal EF hand
(formingCa2CaM) and then two to the amino orN-terminal EF hand (forming
Ca4CaM).We adapt a previous equilibriummodel of Ca binding that includes
[K] dependence (10), to which we added a biphasic dependence on [Mg] (11)
by estimating intrinsic binding constants, as described previously (12). As Ca
binding is cooperativewithin eachEFhand (10),we simpliﬁedCabinding to a
sequential two-step process (see Fig. 1B), where at physiologic [K] and [Mg],
C-terminal and N-terminal EF hands have apparent Kds of 3.1 and 24 mM,
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respectively. We have added kinetics by incorporating consensus fast
N-terminal (500 s1) and slow C-terminal (10 s1) off rates as measured by
stopped-ﬂow experiments and NMR (13). The resulting model fairly accu-
rately predicts overall Ca binding (Fig. 2 A) and kinetics for a wide range of
[Ca], [K], and [Mg] in a manner consistent with many prior studies (11–13).
Under transient conditions, the low-afﬁnity N-terminal lobe of CaM may
potentially bindCa before theC-terminal lobe does, asN-terminal kinetics are
much faster (14). To examinewhetherN-terminal Ca2CaM is prominent in the
context of our cardiac myocyte model, we added this state and compared the
predictions of four-state versus three-state CaM models for dyadic and cy-
tosolic Ca transients. We found that under the conditions examined here,
N-terminal Ca2CaM was insigniﬁcant and the two models gave equivalent
predictions (see the SupplementaryMaterial, Fig. S1,Data S1). Therefore, the
three-state CaMmodel was retained in our studies, as it considerably reduces
the number of uncertain parameters and states required to model interactions
between CaM and CaM targets.
CaMKIId activation module
CaMKII is a multimeric enzyme composed of 10–12 similar subunits, each
of which can bind Ca4CaM for activation and, once activated, can auto-
phosphorylate neighboring subunits at Thr287 to sustain activation (15).
Thr287-phosphorylated subunits bind Ca4CaM very tightly (16), yet retain
activity even when CaM dissociates. Here, we adapted a previous CaMKII
autophosphorylation model (6,17), where the autophosphorylation rate con-
stant is an increasing cubic function of the average number of active subunits
in theCaMKII holoenzyme. This captures the qualitative cooperative features
of CaMKII intraholoenzyme autophosphorylation (e.g., multiple subunits)
while retaining characteristics of a simple model that has been shown to be
consistent with steady-state and kinetic experimental data (6,17). To reﬂect
differences for the cardiac CaMKIId isoform, we incorporated recent data for
Ca4CaM/CaMKIId afﬁnity and rate of CaMKIId autophosphorylation (6). In
nonsaturating Ca/CaM conditions (like in vivo), Ca2CaMmay bind CaMKII
and then recruit additional Ca to form active Ca4CaM/CaMKII, even though
Ca2CaM/CaMKII itself exhibits ,7% activity (18). Likewise, Ca dissocia-
tion from Ca4CaM/CaMKII may be an important inactivation pathway
(16,19). Therefore,we includedCa/Ca2CaM/CaMKII reactions (assuming no
Ca2CaM/CaMKII activity), as well as CaMKII dephosphorylation by protein
phosphatase 1 (PP1) (20) in our model. The six modeled CaMKII states (see
Fig. 1 C) are inactive (Pi); Ca2CaM-bound (Pb2); Ca4CaM-bound (Pb);
Thr287P and Ca4CaM-bound (Pt); Thr
287P and Ca2CaM-bound (Pt2); and
Thr287P but CaM-autonomous (Pa). All active CaMKII states (Pb, Pt, Pt2, Pa)
were assumed to have 100% activity, although the model was insensitive to
FIGURE 1 Model of calmodulin
(CaM)-dependent signaling in cardiac
myocytes. (A) Compartmental model
schematic of cardiac myocyte EC cou-
pling (7) incorporating CaM, CaMKII,
and CaN signaling in thedyadic cleft
and cytosol, as described in Methods.
(B) Reaction map for cooperative Ca
binding of 2 Ca to CaM sequentially to
the C-terminal and then N-terminal EF
hands, along with binding of CaM
‘‘buffers’’. (C) Probabilistic model of
CaMKIId subunit switching between
inactive (Pi), inactive Ca2CaM-bound
(Pb2), active Ca4CaM-bound (Pb),
Thr287-autophosphorylated with Ca4-
CaM trapped (Pt), and Thr
287-autophos-
phorylated but CaM-autonomous (Pa)
or Ca2CaM-bound (Pt2) states. (D) Re-
action map for reversible binding of
CaM, Ca2CaM, and Ca4CaM to CaN.
TABLE 1 Ca/CaM binding and CaM buffering parameters
Parameter Value Units Description References
k20 10 s
1 2 Ca dissociation from CaM (13)*
k02 k20/Kd02 mM
2 s1 2 Ca association with CaM (10,11)y
k42 500 s
1 2 Ca dissocation from CaM (13)*
k24 k42/Kd24 mM
2 s1 2 Ca association with CaM (10,11)y
k0Boff 0.0014 s
1 CaM dissociation from Buffer (23)*
k0Bon k0Boff/0.2 mM
1 s1 CaM association with Buffer (23)*
k2Boff k0Boff/100 s
1 Ca2CaM dissocation from Buffer (23)
z
k2Bon k0Bon mM
1 s1 Ca2CaM association with Buffer —
k4Boff k0Boff/100 s
1 Ca4CaM dissocation from Buffer (23)
z
k4Bon k0Bon mM
1 s1 Ca4CaM association with Buffer —
k42B k42 s
1 2 Ca dissocation from CaMBuffer Detailed balancey
k24B k24 mM
2 s1 2 Ca association with CaMBuffer —
k20B k20/100 s
1 2 Ca dissocation from CaMBuffer Detailed balancey
k02B k02 mM
2 s1 2 Ca association with CaMBuffer —
Parameters are direct (*), derived (y), or estimated (z) from cited sources.
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this assumption because Pt2 and Pa were less occupied in these studies. As
shown in Fig. 2, C–E, and described in the Results section, this model ac-
curately predicts the multiple relationships between [Ca], [CaM], [PP1], and
CaMKII activity seen experimentally.
CaN activation module
Calcineurin binds Ca-saturated CaM (Ca4CaM) with very high afﬁnity (21).
Recent kinetic experiments have directly measured kinetic rates of CaM/CaN
interaction, ﬁnding a Kd of 28 pM (5). Stemmer and Klee measured Ca af-
ﬁnities of CaM in the presence and absence of CaN’s CaM binding domain
(11), which we use together with detailed balance to derive relative afﬁnities
of CaN for Ca2CaM and CaM. The use of relative afﬁnities accounts for the
higher afﬁnity of CaM for intact CaN than for CaN’s CaM binding domain
alone (11). Although the number of Ca ions needed to support CaN activity
has not been measured directly, we assume that Ca4CaM is required for
activity based on the high Hill coefﬁcient (n ¼ 3) for CaN activity (11).
CaN’s constitutively bound subunit, calcineurin B, binds four Ca ions,
which stimulates 10%CaN activity but is also a prerequisite for CaM binding
(11,22). We model only binding of the second pair of Ca ions to calcineurin
B (Kd ¼ 0.5 mM), because the ﬁrst two Ca sites are saturated even in
the presence of strong Ca chelators (Kd ¼ 0.01 mM) (11). We incorpo-
rated the above reaction mechanisms into a multistep binding model, where
Ca4CaMCaN exhibits 100% activity, whereas Ca4CaN, CaMCaN, and
Ca2CaMCaN exhibit 10% activity (see Fig. 1D). The predicted relationships
between [Ca], [CaM], and CaN activity were validated against experimental
data from Fig. 1 of Stemmer and Klee (11) that were not used to parameterize
the model (Fig. 2 B).
CaM buffering
It was found in a recent study that measured CaM buffering in resting cardiac
myocytes that only;60 nM of the total 6mMCaM is free in the cytosol (23).
Furthermore, CaM dissociates from these intracellular targets ;100 times
more slowly at 500 nM [Ca] than at 100 nM (23). To reﬂect this under-
standing in our model, we lumped all CaM targets not explicitly included in
our model into a single CaMbuffer with 100-fold slower dissociation of CaM
when in Ca-bound states than when Ca free (see Fig. 1 B). Estimating free
CaM buffers to be;20mM (3) and freeCaMat rest to be 60 nM (23), the ‘‘Ca
free’’ dissociation constant between CaM and CaM buffer ‘‘B’’ was calcu-
lated to be 0.2 mM. The principle of detailed balance was used to determine
consistent afﬁnities of Ca for CaM/B complexes. This model, summarized in
Fig. 1B, was sufﬁcient to capture the known characteristics of CaMbuffering,
such as limited free CaM at rest and signiﬁcant increase in CaM binding to
buffers at [Ca]. 500 nM (see Fig. 3).
Model of myocyte CaM signaling during
EC coupling
After validating individual modules with in vitro data, we incorporated reac-
tions for CaM, CaMKII, CaN, and CaM buffering into a previously described
and validated model of excitation-contraction coupling in the adult rabbit
ventricular myocyte (7,8). This model includes calcium transport between
several compartments: the dyadic cleft (site of calcium-induced calcium re-
lease), a subsarcolemmal space, cytosol, and the sarcoplasmic reticulum (SR)
(Fig. 1A). TotalCaMwas set at 6mM(24,25), andCaMbuffers (BTOT)were set
TABLE 2 CaMKII reaction parameters
Parameter Value Units Description References
kbi 2.2 s
1 Ca4CaM dissociation from Pb (6,16)*
kib kbi/33.5e-3 mM
1 s1 Ca4CaM association with Pi (6)*
kb2i 5kib2 s
1 Ca2CaM dissociation from Pb2 (18)*
kib2 kib mM
1 s1 Ca2CaM association with Pi —
kb42 k42*33.5e-3/5 s
1 2 Ca dissociation from Pb Detailed balance
y
kb24 k24 mM
2 s1 2 Ca association with Pb2 —
kta kbi/1000 s
1 Ca4CaM dissociation from Pt (16,17)*
kat kib mM
1 s1 Ca4CaM association with Pa (17)*
kt2a 5kib s
1 Ca2CaM dissociation from Pt2 (18)*
kat2 kib mM
1 s1 Ca2CaM association with Pa —
kt42 k42*33.5e-6/5 s
1 2 Ca dissociation from Pt Detailed balance
y
kt24 k24 mM
2 s1 2 Ca association with Pt2 —
kPP1 1.72 s
1 Thr287 dephosphorylated (20)*
KmPP1 11.5 mM Thr
287 dephosphorylated (20)*
Parameters are direct (*) or derived (y) from cited sources.
TABLE 3 CaN reaction parameters
Parameter Value Units Description References
kCaNCaoff 1 s
1 2 Ca dissociation from Ca4CaN (70)*
kCaNCaon kCaNCaoff/0.5 mM
2 s1 2 Ca association with Ca2CaN (11)*
kCaN4off 1.3e-3 s
1 Ca4CaM dissociation from CaN (5)*
kCaN4on 46 mM
1 s1 Ca4CaM association with CaN (5)*
kCaN2off 2508 kCaN4off s
1 Ca2CaM dissociation from CaN (11)
y
kCaN2on kCaN4on mM
1 s1 Ca2CaM association with CaN —
kCaN0off 165 kCaN2off s
1 CaM dissociation from CaN (11)y
kCaN0on kCaN2on mM
1 s1 CaM association with CaN —
k20CaN k20/165 s
1 2 Ca dissociation from CaN Detailed balancey
k02CaN k02 mM
2 s1 2 Ca association with CaN —
k42CaN k42/2508 s
1 2 Ca dissociation from CaN Detailed balancey
k24CaN k24 mM
2 s1 2 Ca association with CaN —
Parameters are direct (*) or derived (y) from cited sources.
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to 26mM(20mMfree1 6mMbound). The fraction ofCaMbuffers in the dyad
was adjusted to obtain a dyadic CaM concentration of 422 mM (0.35 mmol/L
cytosol) at rest, based on one CaM bound per L-type Ca channel or ryanodine
receptor (RyR) monomer (26). This estimate is consistent with calculations of
;25CaMmolecules in the vicinity of each L-type Ca channel (27) and reﬂects
local enrichment of CaMwithin this small compartment. Model predictions of
dyadic cleft CaMKII or CaN signaling were affected ,15% by fourfold in-
creases or decreases in dyadic [CaM]. Results were very insensitive to varying
BTOT over a 10–100mMrange. Due to limited information on subsarcolemmal
CaM/CaMKII/CaN signaling, we assumed the same concentrations as in the
cytosol but did not analyze this compartment in detail here.
Free CaM diffusion between subsarcolemma and cytosol was modeled
using data of CaM diffusivity (28) along with geometries used by Shannon
et al. to model Ca diffusion between these compartments (7). As dyadic CaM
is tethered to the L-type Ca channel or RyR (26,27) and there is a separation
between kinetics of CaM dissociation and free CaM diffusion of more than
three orders of magnitude, we assumed reaction-limited CaM transport be-
tween dyad and subsarcolemma. Thuswemodeled dyadic/sarcolemmalCaM
transport using the same kinetics as in our overall CaM buffer reactions.
We estimate a total subunit [CaMKII] of 0.2mmol/L cytosol by comparing
speciﬁc activity of puriﬁed CaMKII (29,30) with total CaMKII activity in
ventricular homogenates (31). We estimate a total [CaN] of 3 nmol/L cytosol
by comparing speciﬁc activity of puriﬁed CaN (32) with total CaN activity in
adult cardiac myocytes (33). As the quantitative distribution of CaMKII and
CaN between dyadic cleft and cytosolic compartments is unknown, we use
themodel to test how various distributions affect their responsiveness to local
Ca signals (see Figs. 5–8). Kinetic parameters were obtained from in vitro
experiments at ,37C due to limited available data (CaM and CaN, 30C;
CaMKII, 0C). However, model predictions of dyad versus cytosolic activ-
ities or CaMKII versus CaN activities were very insensitive to changes in
kinetic rates reﬂecting average levels of parameter uncertainty (see Fig. S2
and Data S1). Based on a comparison of ventricular homogenate phosphatase
1 (PP1) activity (34,35) and speciﬁc activity of puriﬁed PP1 (36), we estimate
a total cellular PP1 of 0.65 mmol/L cytosol. Based on evidence of PP1 teth-
ering to the RyR complex (37), we assumed 1 PP1/RyR tetramer (96.5mM in
the dyad) resulting in a cytosolic concentration of 0.57 mM. Dyadic CaMKII
activities were very insensitive for up to 10-fold changes in dyadic [PP1], but
note the dramatic effects of eliminating PP1 tethering (see Fig. 5 C).
RESULTS
Properties of CaM, CaMKII, and CaN modules
in vitro
To assess the extent towhich our simple yet biochemistry-based
reaction models of CaM, CaMKII, and CaN could predict
measured characteristics in vitro, we compared model predic-
tions to published experimental data independent from that used
to build the model. There are no error bars in the experimental
data from the literature plotted in Fig. 2,A–D, because theywere
not provided in the original publications. By incorporating data
on how [K] and [Mg] affect the apparent Ca afﬁnities of CaM
(10,11), our two-stepmodel of CaM activation could accurately
FIGURE 2 In vitro validation of model com-
ponents. (A) Model-predicted Ca binding to
CaM at 1 mM or 6 mM [Mg21] and 100 mM
[K1] (experimental data from Stemmer and
Klee (11)). (B) Predicted [Ca] versus CaN
activity for 0.03 and 0.3 mM [CaM, (experi-
mental data from Stemmer and Klee (11)). (C
and D) Predicted [CaM] versus CaM-dependent
CaMKIId activity (C) and CaMKIId-Thr287
activity (D) (independent experimental data
from Gaertner et al. (6)). (E) Predicted [Ca]
versus CaM-dependent CaMKIId activity, com-
pared with independent CaMKIIa data from
Bradshaw et al. (20). (F) Predicted Thr287
P-dependent CaMKIId activity for 0 or 2.5
mM [PP1] (independent CaMKIIa data from
Bradshaw et al. (20)).
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reproduce overall Ca binding characteristics for new combina-
tions of [Ca], [K], and [Mg] seen experimentally (11) (see Fig.
2 A), which is also broadly consistent with many other CaM
studies (12,13).As noted inMethods, only the [Mg] dependence
of CaMwas obtained from Stemmer andKlee (11); the intrinsic
Ca afﬁnities, [K] dependence, and kinetics of CaM were ob-
tained fromother cited sources.CaM-dependentCaN regulation
wasmodeled as reversible associations betweenCaM,Ca2CaM,
Ca4CaM, and CaN (see Fig. 1 D). Model predictions of [Ca]
versus CaN activity for 0.03–0.3mM [CaM] (Fig. 2 B) are quite
consistent with the leftward shift observed in independent ex-
perimental data with 3 nM [CaN], 140 mM [K], and 0.5 mM
[Mg] (11). Although three parameters in the CaN module were
obtained from Stemmer and Klee (11) (kCaN2off, kCaN4off, and
kCaCaNon), these parameters were determined from experiments
independent of the validation data shown in Fig. 2 B.
Using CaMKIId-speciﬁc parameters for Ca4CaM binding
afﬁnity and autophosphorylation rate in the model, we could
also reproduce experimental relationships between [CaM]
and CaM-dependent activity or Thr287-autophosphorylation-
dependent CaMKII activity (6) (Fig. 2, C and D). Although
our model used binding data of [CaM] with CaMKII from
Gaertner et al. (6), the data shown in Fig. 2, C and D, are
separate activity data from the same article. To even more
stringently validate our model of CaMKIId activity, we ex-
amined the relationship between [Ca] and CaMKII activity
for ﬁxed [CaM]. Similar to our above validations of CaM,
we found that [K] and [Mg] dependence of CaM activation
was critical for validation of CaM-dependent processes
with in vitro data, which are often obtained at concentrations
far from in vivo settings. We could reasonably predict the
relationship between [Ca] and CaM-dependent activity of
CaMKIId at 200 mM [K] and 2 mM [Mg], as performed
for CaMKIIa experimentally (20) (Fig. 2 E), by considering
the known higher afﬁnity of CaMKIId (6). However, phys-
iologic ionic concentrations (135 mM [K] and 1 mM [Mg]
in the model) shift the model predictions leftward signiﬁ-
cantly (not shown). We also found that the model could ac-
curately predict both the EC50 and cooperativity in the
relationship between [Ca] and CaM-independent CaMKII
(Thr287-autophosphorylated) activity for 0 and 2.5 mM [PP1]
seen experimentally with CaMKIIa (20) (Fig. 2 F), as
these relationships have not been published for CaMKIId.
By comparing relationships for CaM activation, CaM-de-
pendent CaMKII activity, CaMKII autophosphorylation, and
PP1-dependent CaMKII dephosphorylation in model and
experiment, we show that this fairly simple yet biochem-
ically based model of CaMKII can predict many known
properties of its function in vitro to within one standard de-
viation (except for Fig. 2 E, noting known isoform differ-
ences) without curve-ﬁtting to validation data sets. These
tests are important for justifying subsequent simulations in
which CaMKII is modeled in the context of a beating cardiac
myocyte.
Model of CaM buffering in cardiac myocytes
In addition to CaN and CaMKII, CaM binds to many other
proteins and is thus highly buffered. Although CaM buffering
has not been studied extensively in myocytes, we developed a
simple lumpedmodel of CaM buffering constrained by recent
measurements of free and bound CaM in adult myocytes (23),
as described in Methods (see also Fig. 1 B). As shown in Fig.
3 A, this model could accurately reproduce binding kinetics
between CaM and buffers, which is 100 times slower at 500
nM [Ca] compared with resting levels (100 nM). Note that in
experiments (23), ﬂuorescently labeled CaM was used, and
our simulation uses 16 nM CaM to mimic the incomplete
washout attained experimentally. Although it is currently
unknown whether Ca2CaM dissociates from these buffers at
the same rate as Ca4CaM, this was the rate required for the
model to predict a signiﬁcant shift from ‘‘slow’’ to ‘‘fast’’
dissociation from buffers during the moderate drop from 500
to 100 nM [Ca]. The model predicts a signiﬁcant decrease in
free [CaM] from 1% free (60 nM) to 0.3%with elevated [Ca].
This increased CaM binding is consistent with data showing
signiﬁcantly increased binding of ﬂuorescently labeled CaM
in permeabilized myocytes held at high [Ca] (23), suggesting
FIGURE 3 Model of CaM buffering. (A) Predicted kinetics of CaM/buffer
interaction in permeabilized cardiac myocytes, with slower dissociation at
high [Ca] (experimental data fromWu and Bers (23)). (B) As [Ca] increases,
buffered CaM is predicted to switch from CaMB (solid line) to Ca2CaMB
(dashed line) to Ca4CaMB (dotted line).
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that competition for CaM may become even more intense as
Ca rises during the heartbeat. As steady-state [Ca] increases,
the model predicts switching of buffered CaM from Ca-free
CaMB states at 100 nM to Ca2CaMB at 500 nM [Ca] and
Ca4CaMBat [Ca]. 30mM(see Fig. 3B), which is somewhat
more sensitive than free CaM (where switching from CaM to
Ca2CaM occurs at 3 mM [Ca]).
Beat-to-beat CaM dynamics in dyadic cleft
and cytosol
We incorporated the above reactions for CaM, CaMKII,
CaN, and CaM buffering into a well validated model of
cardiac myocyte EC coupling (7) (see Methods). At each
heartbeat, voltage- and Ca-dependent Ca ﬂuxes cause a large
spike in dyadic-cleft [Ca]. Ca then diffuses to the cytosol to
form the Ca transient. In response to this Ca surge, the model
predicts that dyadic-cleft CaM is rapidly saturated with Ca
(forming Ca4CaM). But as [Ca] drops, two Ca ions dissociate
rapidly from the N-terminal EF hand (t ; 19 ms) and then
the remaining two Ca ions dissociate more slowly from the
C-terminal EF hand (t ; 157 ms) (Fig. 4 A). In contrast,
cytosolic [Ca] appears insufﬁcient for signiﬁcant Ca binding
to CaM, and Ca binding occurs almost exclusively as Ca2-
CaM which does not strongly activate CaN or CaMKII (Fig.
4 B). Upon increasing pacing frequency from 1 to 4 Hz to
simulate faster heart rates, dyadic-cleft Ca4CaM is still
strongly activated but does not accumulate additional base-
line activity (Fig. 4 C), whereas in the cytosol, the model
predicts a slight increase in activated CaM and some accu-
mulation, but the total activity is still extremely small (Fig.
4 D). Assuming similar [CaM] and buffer between sub-
sarcolemma and cytosol, we predict subsarcolemmal Ca4-
CaM signals with magnitudes between those of the dyadic
cleft and the cytosol (Fig. 4E). The very different responses of
CaM in dyadic cleft and cytosol are likely to strongly affect
CaM-dependent signaling pathways localized in these com-
partments.
FIGURE 4 Local CaM dynamics in a model
of a beating cardiac myocyte. (A) Ca2CaM and
Ca4CaM are strongly activated during each beat
in the dyadic cleft. (B) Only a small fraction of
CaM binds Ca in the cytosol with 1 Hz pacing.
Ca dissociates very rapidly from Ca4CaM and
more slowly from Ca2CaM. (C) When pacing
rate is increased from 1 to 4 Hz, Ca4CaM still
does not accumulate in the dyadic cleft. (D)
Ca4CaM only slightly accumulates activity in
the cytosol. (E) Subsarcolemmal Ca4CaM sig-
nals are predicted to lie between dyadic and
cytosolic [Ca4CaM].
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Local dynamics of CaMKII activation
With very strong CaM signals in the dyadic cleft, at each
heartbeat, CaMKII subunits are predicted to fully activate and
then more slowly dissociate CaM throughout diastole (Fig.
5 A). As pacing frequency is increased from 1 to 4 Hz, dyadic-
cleft CaM-dependent CaMKII activity is maintained through-
out diastole, resulting in a substantial increase inmeanCaMKII
activity (Fig. 5 A). However, due to high local [PP1] in the
dyadic cleft, Thr287 autophosphorylation of CaMKII is re-
stricted to,1%, even at increased pacing rates (see Fig. 5 B).
When PP1 tethering to the RyR is disrupted, as occurs in heart
failure (37) (dyadic [PP1] reduced from 96.5 to 0.57 mM),
dyadic CaMKII autophosphorylation is predicted to rise con-
siderably (Fig. 5 B). These predictions are consistent with
experimental data showing very little autophosphorylation in
normal ventricular myocytes unless pacing is combined with
PP1 inhibition (38), yet highly elevated CaMKII autophos-
phorylation in heart failure (39).
In the cytosol, the low CaM signals are insufﬁcient to ac-
tivate CaMKII, so that only 8 in 106 subunits activate even at
4 Hz (Fig. 5 C). Unlike CaN (see Fig. 6 B), in all simulations,
CaMKII kinetics achieved the steady states shown within
seconds. Thus, in the dyadic cleft, CaMKII is quite responsive
FIGURE 5 Predicted local CaMKII dynamics in beating cardiac myo-
cytes. (A) Dyadic-cleft CaMKII activity increases signiﬁcantly from 1 (solid
line) to 4 Hz pacing (dashed line). (B) Dyadic-cleft CaMKII-Thr287P
autophosphorylation is minimal under normal conditions, unless PP1 teth-
ering to RyR is disrupted, as seen in heart failure (37,39). (C) Cytosolic
CaMKII activity remains very low at 1 and 4 Hz.
FIGURE 6 Predicted local calcineurin dynamics in beating cardiac myo-
cytes. (A) Even at low heart rates, any CaN in the dyadic cleft remains fully
locked in an activated state due to its slow dissociation of Ca4CaM. (B)
When pacing is increased from 0.5 to 4 Hz, cytosolic CaN activity slowly
accumulates activity from previous beats with t ; 15 min. (C) Cytosolic
CaN is fairly sensitive to pacing rate, integrating dynamic Ca signals with
activity somewhat higher than in response to a constant signal ﬁxed at the
mean cytosolic [Ca].
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to local Ca signals and exhibits frequency-dependent activity
but little autophosphorylation, whereas in the cytosol the
limited Ca-CaM appears insufﬁcient for CaMKII activity.
Local dynamics of calcineurin activation
Compared with CaMKII, CaN has a much higher afﬁnity for
CaM, and this appears to have a great impact on its response to
local Ca signals. Inmodel simulations, CaN in the dyadic cleft
remained locked in a fully activated state as it did not disso-
ciate from CaM between heartbeats (Fig. 6 A). In the cytosol,
its high afﬁnity for CaM allows it to better compete for the
very small free CaM pool. In contrast to the rapid responses of
CaMKII (Fig. 5), CaN exhibited gradual responses to changes
in heart rate from 1 to 4Hz (t; 2min) (Fig. 6B). Steady-state
cytosolic CaN activity increases with increasing pacing rates
(Fig. 6 C). As shown in Fig. 6 C (lower dashed line), the CaN
response to oscillatingCa signals is similar to the response to a
constant Ca signal ﬁxed at the mean [Ca]i for that pacing rate
(not the peak). Thus, dyadic-cleft CaN is predicted to be max-
imally active but unresponsive to altered Ca signals, whereas
cytosolic CaN exhibits gradual increases in activity in response
to increased pacing rates.
CaM afﬁnity determines differential local CaMKII
and CaN activities
Why do predictions of CaMKII and CaN differ so greatly?
One answer could be their different activation mechanisms.
CaN requires Ca before CaMassociation and can bindCa-free
CaM. In contrast, CaMKII binds only Ca2CaM or Ca4CaM
and exhibits autophosphorylation. We hypothesized that al-
though the speciﬁc reaction mechanisms for CaMKII and
CaN activation differ, their different afﬁnities for Ca4CaM
could substantially explain their predicted divergent re-
sponses to local Ca signals. To test this hypothesis in the
model, we perturbed the rate constants of CaN and CaMKII
for Ca4CaM to switch their CaM afﬁnities: CaN from Kd
0.028–33.5 nM, and CaMKII from Kd 33.5–0.028 nM.
Switching CaMKII from a low- to a high-afﬁnity CaM target
increased cytosolic activity (Fig. 7 A) and locked dyadic-cleft
CaMKII in amaximally activated state (not shown). Switching
CaN from a high- to a low-afﬁnity CaM target allowed dyadic-
cleft CaN to vary signiﬁcantly from beat to beat, at the same
time retaining strong activity (Fig. 7B), whereas cytosolic CaN
activity diminished considerably (Fig. 7C). Overall, switching
CaMafﬁnities ofCaMKII andCaN substantially switched their
functional responses to local Ca signals, demonstrating that
CaM afﬁnity is a strong determinant of response to local Ca.
Role of CaM availability on CaMKII and
CaN activation
To better understand the role of CaM buffering on selective
CaMKII and CaN activation, we performed simulations in
which CaM buffering was removed (i.e., free CaMwas set to
6mMand all CaMwas available to interact with CaMKII and
CaN). Even with sarcolemmal (SL) and cytosolic CaM
buffers removed (BTOT-SL ¼ 0, BTOT-CYT ¼ 0), ,0.01% of
cytosolic CaMKII subunits were activated during pacing
(Fig. 8A). RemovingCaMbuffering elevatedCaNactivity at
all pacing rates (Fig. 8 B). These model results suggest that
the low [Ca] and [Ca4CaM] in the cytosol are insufﬁcient for
robust cytosolic CaMKII activation, even in conditions with
enhanced CaM availability. In contrast, low CaM avail-
ability puts a signiﬁcant brake on cytosolic CaN activity,
which may prevent constitutive CaN activity at resting heart
rates for rabbit.
Role of Ca and Ca2CaM dissociation from
Ca-CaM-target complexes
In addition to deactivation by Ca4CaM dissociation, both
CaMKII and CaN models include reactions for reversible
dissociation of two Ca from the Ca4CaM-target complex
FIGURE 7 Reversing CaM afﬁnity switches characteristic local activa-
tion patterns of CaMKII and CaN. Increasing CaMKII’s afﬁnity for Ca4CaM
to that of CaN (28 pM) enhances cytosolic activity (A) yet locks dyadic-cleft
CaMKII in a fully activated state. Lowering CaN’s afﬁnity for Ca4CaM to
that of CaMKII (33.5 nM) allows appreciable beat-to-beat variation of CaN
activity in the dyadic cleft (B) yet substantially reduces cytosolic CaN
activity (C).
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and subsequent dissociation of Ca2CaM from each target,
based on prior biochemical studies (11,18,19). To examine
the signiﬁcance of these reactions in the cellular context, we
ran additional simulations in which only Ca4CaM (and not
Ca2CaM) could bind to CaMKII and CaN. With Ca4CaM
dissociation as the only available deactivation pathway,
CaMKII (Fig. 9 A) and CaN deactivation slowed consider-
ably, indicating that Ca dissociation from target-associated
Ca4CaM is the dominant form of deactivation for both CaM
targets. Furthermore, with Ca4CaM association as the only
activation pathway, dyadic CaMKII activity was partially
reduced (Fig. 9 A) and cytosolic CaN activity was greatly
diminished (Fig. 9 B). This indicates that Ca2CaM binding to
targets, with subsequent recruitment of Ca to form Ca4CaM-
target complexes, may be the favored activation pathway in
compartments with limited CaM. This occurred despite little
activity of the Ca2CaM-target complex itself and signiﬁ-
cantly greater afﬁnity of CaMKII and CaN for Ca4CaM than
for Ca2CaM, because cytosolic [Ca2CaM] far exceeded cy-
tosolic [Ca4CaM] (see Fig. 4 B).
DISCUSSION
It is currently unclear how Ca-dependent signaling pathways
in the heart are selectively regulated. Furthermore, the local
Ca signals relevant to key Ca-dependent pathways such as
CaMKII and CaN have not been identiﬁed (2). Here, we
developed what we believe is a novel computational model of
the ventricular myocyte to investigate molecular mechanisms
of differential spatial and temporal control of CaM, CaMKII,
and CaN activities that may underlie selective pathway ac-
tivation.
CaM dynamics in ventricular myocytes
Due to intense competitionbetweenCaMtargets,CaMhasbeen
described as a limiting factor to cell signaling (3). Free CaM is
only ;1% of total CaM in resting adult ventricular myocytes
(23) and smooth muscle (40,41), and our model of CaM buff-
ering predicts that competition for CaM becomes even more
intense as [Ca] rises. Using a biosensor for Ca-CaM expressed
in adult ventricular myocytes, Maier et al. found measurable
beat-to-beat Ca-CaM oscillations only when overexpressing
CaM (25). This is consistent with our prediction that cytosolic
Ca-CaM oscillations with normal CaM levels are very small,
likely below the threshold of detection by low-afﬁnity Ca-CaM
sensors.
Our model predictions are consistent with these prior
studies and provide additional mechanistic insight. In the cy-
tosol, simulations indicated that limited beat-to-beat activation
of Ca-CaM was due not only to limited free CaM (;1% of
total CaM) but also to limited activation of free CaM by cy-
tosolic Ca (;0.5% of free CaM) due to its high apparent Kd
(10 mM) compared with cytosolic [Ca]. A directly testable
model prediction is that sustained very high [Ca] should ac-
FIGURE 8 Role of CaM buffering in modulating CaMKII and CaN
activation. Increasing CaM availability by eliminating CaM sarcolemmal
and cytosolic CaM buffers (BTOT-SL ¼ 0, BTOT-CYT ¼ 0) (dashed lines) is
insufﬁcient to substantially activate cytosolic CaMKII (A), but signiﬁcantly
enhances cytosolic CaN activity in response to pacing (B).
FIGURE 9 Role of Ca2CaM binding in modulating CaMKII and CaN
activation. (A) Eliminating binding reactions between Ca2CaM and CaMKII
reduced peak dyadic-cleft CaMKII activity and slowed inactivation, leaving
mean activity relatively unaffected at 1 Hz. (B) Eliminating Ca2CaM binding
substantially suppressed cytosolic CaN activity.
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tivate the CaM biosensor much more strongly than seen
previously with beat-to-beat electrical pacing. In contrast, the
dyadic cleft can exhibit much higher local [Ca] (.50 mM)
than the cytosol, and CaM is highly enriched in this micro-
domain (26,27), both important for the model’s predictions of
robust activation of dyadic Ca-CaM. The signiﬁcance of faster
off-rates of Ca from the N-terminal versus the C-terminal EF
hands of CaM (13) can be observed in the predicted lack of
accumulation of dyadic-cleft Ca4CaM even at high heart rates.
However, bound Ca4CaM may accumulate on high-afﬁnity
CaM targets (such asCaMbuffers orCaN) to allow integration,
as observed with ﬂuorescent CaM biosensors during isopro-
terenol exposure (25) or increased pacing rate (42).
Local CaMKII activity
CaMKIId regulates many important cardiac processes, in-
cluding EC coupling (43,44), apoptosis (45), and transcrip-
tion (46). CaMKIIdC is often referred to as the cytosolic
isoform, because it is excluded from the nucleus compared
with the dB isoform (47). Although CaMKII has substrates in
both dyadic cleft (L-type Ca21 channel, RyR) (44,48) and
cytosol (phospholamban) (49), and immunoprecipitates with
the L-type Ca channel (48) and RyR (50), the quantitative
distribution of CaMKIIdC among extranuclear compartments
is unknown. The local Ca signals regulating CaMKIIdC are
also unknown. Despite the label ‘‘cytosolic’’, our model
predicts that CaMKIIdC is quite insensitive to cytosolic Ca
signals due to limited cytosolic Ca-CaM and a relatively low
afﬁnity of CaMKII for CaM. In contrast, the model predicts
robust beat-to-beat oscillations in CaMKII activity in the
dyadic cleft due to the large local [Ca] and CaM enrichment.
As suggested bybiochemical studies (19), deactivationkinetics
for these oscillations were dominated by Ca dissociation from
the Ca-CaM-CaMKII complex rather than classical Ca4CaM
dissociation.
In addition to regulating EC coupling, CaMKII selectively
regulates hypertrophic gene transcription, yet the mechanism
for selective regulation of contractility versus transcription has
not been identiﬁed (2). If, as predicted by the model, CaMKII
regulation requires subcellular targeting to domains with high
local [Ca], this could potentially explain howCaMKII tethered
to nuclear IP3 receptors can respond to IP3-mediated Ca release
yet be insensitive to beat-to-beatCaoscillations (46).However,
a requirement for high local [Ca] also raises newquestions, as it
becomes unclear how cytosolic CaMKII substrates distant
from the dyadic cleft (e.g., phospholamban) may be regulated.
In neurons, CaM-bound CaMKII translocates to postsynaptic
densities (51), yet CaMKII translocation has not been reported
in cardiac myocytes.
Frequency-dependent CaMKII activity contributes to
L-type Ca21 channel facilitation (52), frequency-dependent
acceleration of relaxation (53), and possibly the positive
force-frequency relationship (54). As heart rate increases in
our model, dyadic cleft CaMKII activity rises signiﬁcantly,
with a ‘‘memory’’ of;1 s, which is consistent with reported
rates of CaMKII-dependent, frequency-dependent accelera-
tion of relaxation (38) and L-type Ca21 channel facilitation
(52) (,5 s), but faster than the time courses for RyR or
phospholamban phosphorylation (;3 min) (38). Frequency-
dependent activity was dictated by the rate of Ca dissociation
from Ca4CaM/CaMKII rather than the magnitude of the Ca
signal or Thr287 autophosphorylation.
CaMKII autophosphorylation is prominent in many cell
types, often correlates with overall CaMKII activity (15), and
can lead to enhanced ‘‘memory’’ or bistability (55). In the heart,
however, the precise conditions that trigger CaMKII auto-
phosphoryation, and its physiologic signiﬁcance, are still under
debate (38,56). In our model, dyadic cleft Thr287 autophos-
phorylation was minimal under normal conditions, consistent
with recent experimental data (38), yet when RyR/PP1 pre-
association was disrupted, as reportedly occurs in heart failure
(37), dyadic CaMKII autophosphorylation was seen to rise
dramatically, as seen with heart failure (39) or PP1 inhibition
(38). It appears that CaMKII may exhibit signiﬁcant auto-
phosphorylation only in pathophysiologic conditions, where
local [PP1] is depleted. Thus, CaMKII appears responsive only
to high [Ca] signals, as are found in the dyadic cleft, and ex-
hibits frequency-dependent activity relevant to the range of
physiologic heart rates, despite minimal autophosphorylation.
Local CaN activity
Calcineurin plays an important role in cardiac hypertrophy via
dephosphorylation of the nuclear factor of activated T cells
(NFAT), and it dephosphorylates several additional sub-
strates in cardiac myocytes (57). CaN docks with several
protein complexes, including the L-type Ca channel (58),
neonatal but not adult RyR2 (37,59), and sarcomeric calsarcin
(60), but may also translocate to the nucleus alongwithNFAT
(61). However, quantitative subcellular distribution of CaN in
adult myocytes is unknown, and the local Ca signals re-
sponsible for its regulation have not been identiﬁed for the
heart (1,2). Here, we found evidence that due to the high af-
ﬁnity of CaN for Ca4CaM, CaN may effectively compete for
the limited cytosolic CaM pool (unlike CaMKII). Cytosolic
CaN was responsive to increased pacing frequency, consis-
tent with data from atrialmyocytes (62), and this responsewas
greatly ampliﬁed when CaM buffering was removed. In re-
sponse to changes in pacing rate, CaN activity reﬂected an
integration of past Ca signals with t ; 3 min. Blocking
Ca2CaM binding to CaN signiﬁcantly dampened CaN activ-
ity, indicating that this is likely the dominant CaN activation
pathway in CaM-limited compartments like the cytosol.
These ﬁndings support the hypothesis that the CaN-NFAT
signaling pathway may be responsive to subtle changes in
cytosolic Ca signals.
At the dyadic cleft, the high [Ca] signals and very slow
dissociation of Ca4CaM/CaN resulted in constitutively active
CaN even with very low pacing frequencies. Thus, CaN tar-
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geted to such Ca release sites is unlikely to participate in the
CaN-NFAT hypertrophic signaling axis (unless Ca-CaM-
CaN can translocate without losing CaM). CaN may act very
differently in different compartments, for example, as a con-
stitutively active phosphatase in regions of high [Ca], and as a
sensitive integrator of Ca signals in regions of low [Ca]. Al-
though CaN translocation has not been observed in cardiac
myocytes, nor is it modeled here, our predicted slow inacti-
vation of Ca4CaM/CaN indicates that CaN potentially trans-
locating from the dyadic cleft or cytosolmay retain activity for
some time, as in other cell types (61).
Role of CaM afﬁnity and availability
CaM-binding proteins exhibit a wide range of afﬁnities, and
limited CaM availability may allow CaM afﬁnity to sensi-
tively affect when and where CaM targets are activated (3).
Alternatively, the different activationmechanisms ofCaMKII
and CaN may underlie their different responses. We found
that by switching the CaM afﬁnities of CaMKII and CaN, we
could essentially reverse their characteristic responses to local
Ca signals in cardiac myocytes. This demonstrates that CaM
afﬁnity is a major determinant of selective responsiveness in
these cells. Tentatively extrapolating to other CaM targets, we
could predict the local Ca signals relevant to targets such as
phosphodiesterase, nitric oxide synthase, and adenylyl cy-
clase based on their known CaM afﬁnities. Although sys-
tematically altering the CaM afﬁnity of endogenous proteins
is difﬁcult in practice, initial experiments comparing ﬂuo-
rescent CaM biosensors of high and lowCaM afﬁnity (similar
to CaN and CaMKII) indicate different frequency-dependent
Ca-CaM responses in adult myocytes (42). Further experi-
ments such as this one will provide opportunities to directly
validate our model predictions.
We found that whereas cytosolic CaMKII could not be
highly activated, even with additional CaM, removing CaM
buffers substantially ampliﬁed cytosolic CaN activity. This
prediction is consistent with experimentally measured beat-to-
beat changes in cytosolic ﬂuorescent CaM biosensors found
only when they are overexpressing CaM (25,42), and could be
further validated in future studies by testing whether CaN-
NFAT activity is more sensitive when CaM is overexpressed.
Thus, CaM buffering (23) may modulate CaN and other Ca
signaling pathways, and altered expression of CaM or CaM-
binding proteins during cardiac disease could potentially re-
model how CaM selectively regulates contractility and gene
transcription.
Limitations
With any mechanistic model built using parameters from the
biochemical literature, one can only reasonably include known
mechanisms, and uncertainty in parameter values is unavoid-
able. However, these models can integrate known molecular
mechanisms into a consistent quantitative framework and can
demonstrate their sufﬁciency, anddiscrepancies betweenmodel
and experiment can be used to identify new mechanisms nec-
essary to explain a phenotype. Only limited information is
available for CaM buffers, and each of these buffers may in-
teract with CaM differently. However, the average CaM buff-
ering behavior should be well represented by the experimental
data used to develop ourmodel (23). Although subcellularCaM
distribution is not fully characterized, we found that a 16-fold
variation in dyadic [CaM] affected results by,15%, and results
were similar in the cytosol.
We have not modeled CaMKII or CaN diffusion due to a
lack of experimental data to support such transport in myo-
cytes. Immunoﬂuorescence data indicate sarcolemmal or
Z-line localization of CaMKII and CaN (63,64), suggesting
that CaMKII and CaN are primarily ﬁxed. However, given
our model predictions of CaMKII and CaN kinetics, we can
anticipate the impact of CaMKII/CaN diffusion should it
occur. Dyadic CaMKII inactivated rapidly under normal
conditions, which would minimize its ability to activate cy-
tosolic targets unless autophosphorylated (which slowed in-
activation). In contrast, CaN inactivated slowly, which may
allow transfer of the CaN signal from the dyad to the cytosol/
nucleus should dyadic CaN translocate. Indeed, CaN has been
reported to detect local Ca signals at neuronal Ca channels
(58) and also to translocate to the nucleus with NFAT (61) in
other cell types.
Here, we have only focused on differences in signaling
between the dyadic-cleft and cytosolic compartments, yet
many other subcellular domains are likely to contain localized
CaM signaling. For example, subsarcolemmal CaM signaling
(including interactions with the sarcolemmal Ca pump, IKs,
and NO synthase) would be expected to be between the ex-
tremes of cleft- and cytosolic-domains CaM signaling that we
have focused on here. However, we have not explored this in
detail, because of limited available data for CaM in this do-
main.We also have not included nuclear CaMKII signaling at
the IP3 receptor (46) or stochastic reactions occurring within
individual protein complexes. Our compartmental model
does not account for cytosolic tethering of Ca-free CaM near
Ca4CaM targets by proteins such as neuromodulin that are
thought to provide local CaM stores in neurons (65). Lack of
detailed information about pretethering of CaM to speciﬁc
Ca4CaM targets may affect our predictions of limited CaM
activation and binding of Ca4CaM targets in the cytosol.
However, our simulations with enhanced CaM availability
(Fig. 8) provide a quantitative indication of how tetheringmay
enhance such interactions.We have focused on only twoCaM
targets, CaMKII andCaN, because they exhibit different CaM
afﬁnities and regulate a diverse set of important cardiac
functions. Future study will be required both to understand
how other endogenous CaM targets (e.g., RyR, NO synthase,
and IKs) are modulated locally and how these local signaling
pathways coordinate their downstream physiological re-
sponses (e.g., apoptosis, contractility, NFAT, or HDAC-de-
pendent transcription). Our model of CaM buffers implicitly
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incorporates the competition for CaM between these un-
modeled CaM targets, CaMKII and CaN. Because our inten-
tionwas to focus on themolecularmechanisms ofCaMKII and
CaN activation, we have not modeled the feedback of CaMKII
activity on Ca channels and pumps, as others have done with
simpler CaM models (54,66). Our new work can now be in-
tegrated with such modeling, including CaMKII-dependent
effects on cardiac ion channels (67), to better understand the
molecular basis of CaMKII-mediated arrhythmias and related
physiology.
We limited our studies to compartmental deterministic
simulations both for simplicity and because such simulations
are computationally feasible for up to 1 h, which is well be-
yond the timescale of published stochastic myocyte models
(68,69). A single dyad contains,100 CaM, CaMKII, or CaN
molecules, which may provide for stochastic variability in
signaling. Stochasticity has been predicted not only to generate
‘‘noise’’, but also to qualitatively affect feedback systems,
including Ca-induced Ca release in the cardiac myocyte dyad
(68,70). Although CaN does not exhibit positive feedback,
CaMKII’s autophosphorylation may be sensitive to stochastic
effects. Bhalla compared stochastic and deterministic simula-
tions of CaMKII at abundances comparable to our dyadic-cleft
model (70). He found that CaMKII autophosphorylation ex-
hibited signiﬁcant noise, but that CaM-dependent CaMKII
activity was very similar to deterministic simulations. Our
simulations predict little CaMKII autophosphorylation due to
high local [PP1] in the dyad, so we expect that stochasticity
may not qualitatively affect whole-cell behavior, except in
cases of PP1 inhibition (like heart failure). Although we have
not incorporated CaMKII regulation of ICa or RyR, these
create additional positive feedbacks which may be sensitive to
stochasticity
Despite inescapable limitations, our computational model
predicts a variety of key features ofCa-dependent signaling in a
manner consistent with the existing independent experimental
data. Furthermore, the model provides what we believe are
novel predictions that highlight the crucial role of CaM afﬁnity
and localization in modulating CaMKII and CaN activity in
cardiacmyocytes. Thesemodel predictions are directly testable
experimentally, with the recent availability of ﬂuorescent re-
porters for CaM binding (25), CaN activity (71), and CaMKII
activity (72). Additional molecular mechanisms can be sys-
tematically integrated with our model as needed.
In conclusion, we developed a computational model that
provides mechanistic insight into the local Ca signals relevant
to CaMKII and CaN pathways in cardiac myocytes, and into
how CaM mediates the differential regulation of these path-
ways in the dyadic cleft and cytosol. CaMKII appears to be
effective only in the dyadic cleft, is frequency-dependent,
shows little autophosphorylation under normal conditions, and
exhibits little memory (fewer than ﬁve heartbeats). In contrast,
CaN appears to be responsive to time-varying Ca signals only
in the cytosol, where its activity reﬂects the integrated cytosolic
Ca signal over several minutes. CaM afﬁnity and availability
are primary determinants for the divergent responses of CaN
and CaMKII to local Ca, and these mechanisms may allow
selective activation of Ca pathways regulating beat-to-beat
contractility (CaMKII) and cardiac hypertrophy (CaN).
APPENDIX
Tables 1–3 provide reaction parameters, along with a note of whether that
parameter was direct (*), derived (y, as described in Methods), or estimated
(z) from cited sources. No curve-ﬁtting was used. Each of the below CaM,
CaMKII, and CaN reactions were included in dyadic cleft, sarcolemmal, and
cytosolic compartments, with compartment-speciﬁc total concentrations as
speciﬁed in Table 4.
CaM reaction ﬂuxes
Reaction ﬂuxes, in units of [mM s1], for reactions of Ca binding to CaM are
as shown in Fig. 1, A and D, and described in Methods. Parameter values are
listed in Table 1.
Reaction02 ¼ k02½Ca2½CaM  k20½Ca2CaM; (2)
Reaction24 ¼ k24½Ca2½Ca2CaM  k42½Ca4CaM; (3)
Reaction02B ¼ k02B½Ca2½CaMB  k20B½Ca2CaMB; (4)
Reaction24B ¼ k24B½Ca2½Ca2CaMB  k42B½Ca4CaMB; (5)
Reaction0B ¼ k0Bon½CaM½B  k0Boff ½CaMB; (6)
Reaction2B ¼ k2Bon½Ca2CaM½B  k2Boff ½Ca2CaMB; (7)
Reaction4B ¼ k4Bon½Ca4CaM½B  k4Boff ½Ca4CaMB: (8)
If ½Mg# 1;
Kd02 ¼ 0:0025ð11 ½K=0:94 ½Mg=0:012Þð11 ½K=8:11 ½Mg=0:022Þ
Kd24 ¼ 0:128ð11 ½K=0:641 ½Mg=0:0014Þð11 ½K=13:0 ½Mg=0:153Þ
if ½Mg. 1;
Kd02 ¼ 0:0025ð11 ½K=0:94 1=0:0121 ð½Mg  1Þ=0:06Þð11 ½K=8:11 1=0:0221 ð½Mg  1Þ=0:068Þ
Kd24 ¼ 0:128ð11 ½K=0:641 1=0:00141 ð½Mg  1Þ=0:005Þð11 ½K=13:0 1=0:1531 ð½Mg  1Þ=0:15Þ; (1)
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Ca binding to CaM and CaM buffering
Differential equations (units in [mMms1]) for concentrations of free CaM,
Ca2CaM, and Ca4CaM, computed separately for each compartment (dyadic
cleft, sarcolemma, and cytosol). In addition, CaM, Ca2CaM, and Ca4CaM
have transport ﬂuxes as follows:


















Transport ﬂuxes for reaction-limited transport of CaM between dyad and
sarcolemma, and free diffusion between sarcolemma and cytosol, are as
shown in Fig. 1 A and described in Methods. Dyad-SL transport ﬂuxes
are in units of [mmol/(L dyad) s1], which requires a VDYAD/VSL conversion
for computing SL concentrations. SL-cytosol ﬂuxes are in units of
[mmol s1], requiring division by VSL or VCYT for the corresponding
compartments. Volumes are from Shannon et al.: VDYAD ¼ 1.79 3 1014 L;
VSL ¼ 6.60 3 1013 L; and VCYT ¼ 2.14 3 1011 L (7). We estimate that
kSLCYT ¼ 8.59 3 1012 L s1 based on diffusivity of free CaM (28) and
myocyte geometry (7).
JCaMDYAD=SL ¼ k0Boff ½CaMDYAD  k0Bon½BDYAD½CaMSL; (16)
JCa2CaMDYAD=SL ¼ k2Boff ½Ca2CaMDYAD
 k2Bon½BDYAD½Ca2CaMSL; (17)
JCa4CaMDYAD=SL ¼ k4Boff ½Ca4CaMDYAD
 k4Bon½BDYAD½Ca4CaMSL; (18)
JCaMSL=CYT ¼ kSLCYTð½CaMSL  ½CaMCYTÞ; (19)
JCa2CaMSL=CYT ¼ kSLCYTð½Ca2CaMSL  ½Ca2CaMCYTÞ; (20)
JCa4CaMSL=CYT ¼ kSLCYTð½Ca4CaMSL  ½Ca4CaMCYTÞ: (21)
CaMKII activation
Six state model of CaMKII activation, as described in Methods. Px are
probabilities ranging from 0 to 1 of a given CaMKII subunit being in a given
state (I, B2, B, T, T2, or A), where the total concentration of subunits in state
‘X’ is Px *[CaMKIITOT]. Differential equations are in units of [msec
-1].
Parameters listed in Table 2.
Pi ¼ 1 Pb  Pb2  Pt  Pt2  Pa; (22)
T ¼ Pb1Pt1Pt21Pa; (23)
kbt ¼ 0:055T1 0:0074T21 0:015T3; (24)
ReactionCKbt ¼ kbtPb  kpp1½PP1totPt
KmPP11 ½CaMKIItotPt; (25)
ReactionCKib2 ¼ kib2½Ca2CaMPi  kb2iPb2; (26)
ReactionCKb2b ¼ kb24½Ca2Pb2  kb42Pb; (27)
ReactionCKib ¼ kib½Ca4CaMPi  kbiPb; (28)
ReactionCKtt2 ¼ kt42Pt  kt24½Ca2Pt2; (29)
ReactionCKta ¼ ktaPt  kat½Ca4CaMPa; (30)





TABLE 4 Protein total concentrations
Parameter Value Units References
CaMTOT 6.0 mM (24,25)*
BTOT-CYT 24.5 mM (23)
z
BTOT-SL BTOT-CYT mM —
BTOT-DYAD 1.86 mM (26,27)
yz
CaMKIITOT-CYT 0.2 (0 by default) mM (29–31)
y
CaMKIITOT-SL CaMKIITOT-CYT mM —
CaMKIITOT-DYAD 120 mM (29–31)
z
CaNTOT-CYT 3e-3 mM (32,33)
y
CaNTOT-SL CaNTOT-CYT mM —
CaNTOT-DYAD 3.62 (0 by default) mM (32,33)
y
PP1TOT-CYT 0.57 mM (34,35)
y
PP1TOT-SL PP1TOT-CYT mM —
PP1TOT-DYAD 96.5 mM (37)
z
Parameters are direct (*), derived (y), or estimated (z) from cited sources.
d½Ca2CaM
dt






¼ 103 Reaction24  Reaction4CaN  Reaction4B
1 ½CaMKIITOTðReactionCKta  ReactionCKibÞ
 
; (12)
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dPb2
dt



















Model of Ca and CaM binding to CaN, as described in Methods. Parameters
listed in Table 3. Differential equation in units of [mM ms1].
½Ca2CaN ¼ ½CaNTOT  ½Ca4CaN  ½CaMCaN
 ½Ca2CaMCaN  ½Ca4CaMCaN; (39)






Reaction0CaN ¼ kCaN0on½CaM½Ca4CaN  kCaN0off ½CaMCaN;
(43)
Reaction2CaN ¼ kCaN2on½Ca2CaM½Ca4CaN
 kCaN2off ½Ca2CaMCaN; (44)
Reaction4CaN ¼ kCaN4on½Ca4CaM½Ca4CaN
 kCaN4off ½Ca4CaMCaN; (45)
d½Ca4CaN
dt
¼ 103ðReactionCa4CaN  Reaction0CaN
 Reaction2CaN  Reaction4CaNÞ; (46)
d½CaMCaN
dt
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